-
1
-
-
0002746856
-
Serum triglycerides in coronary artery disease
-
Albrink MJ, Man EB, Serum triglycerides in coronary artery disease. Arch Intern Med 1959; 103: 4-8.
-
(1959)
Arch Intern Med
, vol.103
, pp. 4-8
-
-
Albrink, M.J.1
Man, E.B.2
-
2
-
-
0001630654
-
Serum triglycerides in health and in ischemic heart disease
-
Brown DF, Kinch SH, Doyle JT. Serum triglycerides in health and in ischemic heart disease. N Engl J Med 1965; 273: 947-52.
-
(1965)
N Engl J Med
, vol.273
, pp. 947-952
-
-
Brown, D.F.1
Kinch, S.H.2
Doyle, J.T.3
-
3
-
-
0027065022
-
Epidemiology of triglycerides. A view from Framingham
-
Castelli WP. Epidemiology of triglycerides. A view from Framingham. Am J Cardiol 1992; 70: 3H-9H.
-
(1992)
Am J Cardiol
, vol.70
, pp. 3H-9H
-
-
Castelli, W.P.1
-
4
-
-
0027924658
-
Triglyceride, high-density lipoprotein, and coronary heart disease. NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease
-
NIH Consensus conference
-
NIH Consensus conference. Triglyceride, high-density lipoprotein, and coronary heart disease. NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease. JAMA 1993; 269: 505-10.
-
(1993)
JAMA
, vol.269
, pp. 505-510
-
-
-
5
-
-
0029838433
-
Plasma triglyceride level is a risk factor for cardiovascular disease independent of HDL cholesterol level: A meta-analysis of population-based prospective studies
-
Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of HDL cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996; 3: 213-9.
-
(1996)
J Cardiovasc Risk
, vol.3
, pp. 213-219
-
-
Hokanson, J.E.1
Austin, M.A.2
-
6
-
-
15944403233
-
Plasma triglycerides and Type III hyperlipidemia are independently associated with premature familial coronary artery disease
-
Hopkins PN, Wu LL, Hunt SC, Brinton EA. Plasma triglycerides and Type III hyperlipidemia are independently associated with premature familial coronary artery disease. J Am Coll Cardiol 2005; 45: 1003-12.
-
(2005)
J am Coll Cardiol
, vol.45
, pp. 1003-1012
-
-
Hopkins, P.N.1
Wu, L.L.2
Hunt, S.C.3
Brinton, E.A.4
-
7
-
-
0035806916
-
Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(A), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study
-
Atherosclerosis Risk in Communities Study Group
-
Sharrett AR, Ballantyne CM, Coady SA, et al. Atherosclerosis Risk in Communities Study Group. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2001; 104: 1108-13.
-
(2001)
Circulation
, vol.104
, pp. 1108-1113
-
-
Sharrett, A.R.1
Ballantyne, C.M.2
Coady, S.A.3
-
8
-
-
84866146620
-
Endocrine society Evaluation and treatment of hypertriglyceridemia: An Endocrine Society clinical practice guideline
-
Berglund L, Brunzell JD, Goldberg AC, et al. Endocrine society Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012; 97: 2969-89.
-
(2012)
J Clin Endocrinol Metab
, vol.97
, pp. 2969-2989
-
-
Berglund, L.1
Brunzell, J.D.2
Goldberg, A.C.3
-
9
-
-
84875813175
-
Severe hypertriglyceridemiarelated acute pancreatitis
-
Stefanutti C, Labbadia G, Morozzi C. Severe hypertriglyceridemiarelated acute pancreatitis. Ther Apher Dial 2013; 17: 130-7.
-
(2013)
Ther Apher Dial
, vol.17
, pp. 130-137
-
-
Stefanutti, C.1
Labbadia, G.2
Morozzi, C.3
-
10
-
-
84881381644
-
Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: The sixth special issue
-
Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Linenberger ML, Szczepiorkowski ZM, Williams ME, Wu Y, Shaz BH. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher 2013; 28(3): 145-284.
-
(2013)
J Clin Apher
, vol.28
, Issue.3
, pp. 145-284
-
-
Schwartz, J.1
Winters, J.L.2
Padmanabhan, A.3
Balogun, R.A.4
Delaney, M.5
Linenberger, M.L.6
Szczepiorkowski, Z.M.7
Williams, M.E.8
Wu, Y.9
Shaz, B.H.10
-
11
-
-
84872172890
-
Treatment options for severe hypertriglyceridemia (SHTG): The role of apheresis
-
Ewald N, Kloer HU. Treatment options for severe hypertriglyceridemia (SHTG): the role of apheresis. Clin Res Cardiol 2012; (1)7: 315.
-
(2012)
Clin Res Cardiol
, vol.7
, Issue.1
, pp. 315
-
-
Ewald, N.1
Kloer, H.U.2
-
13
-
-
0036207653
-
Long-term followup of patients with acute hypertriglyceridemia-induced pancreatitis
-
Athyros VG, Giouleme OI, Nikolaidis NL, et al. Long-term followup of patients with acute hypertriglyceridemia-induced pancreatitis. J Clin Gastroenterol 2002; 34: 4725.
-
(2002)
J Clin Gastroenterol
, vol.34
, pp. 4725
-
-
Athyros, V.G.1
Giouleme, O.I.2
Nikolaidis, N.L.3
-
14
-
-
0027399274
-
Metabolism of triglyceride rich lipoproteins during alimentary lipemia
-
Karpe F, Steiner G, Olivecrona T, Carlson LA, Hamsten A. Metabolism of triglyceride rich lipoproteins during alimentary lipemia. J Clin Invest1993; 91: 748-58.
-
J Clin Invest1993
, vol.91
, pp. 748-758
-
-
Karpe, F.1
Steiner, G.2
Olivecrona, T.3
Carlson, L.A.4
Hamsten, A.5
-
15
-
-
79955582390
-
Assessment and Clinical Relevance of Non-Fasting and Postparandial Triglycerides: An Expert Panel Statement
-
Kolovou GD, Mikhailidis DP, Kovar J, et al. Assessment and Clinical Relevance of Non-Fasting and Postparandial Triglycerides: An Expert Panel Statement. Curr Vas Pharmacol 2011; 9: 258-70.
-
(2011)
Curr Vas Pharmacol
, vol.9
, pp. 258-270
-
-
Kolovou, G.D.1
Mikhailidis, D.P.2
Kovar, J.3
-
17
-
-
0026354893
-
Structure and metabolism of low density lipoproteins from normal and hypertriglyceridemic subjects
-
McKeone BJ, Patsch JR, Pownall HJ. Structure and metabolism of low density lipoproteins from normal and hypertriglyceridemic subjects. Adv Exp Med Biol 1991; 285: 289-93.
-
(1991)
Adv Exp Med Biol
, vol.285
, pp. 289-293
-
-
McKeone, B.J.1
Patsch, J.R.2
Pownall, H.J.3
-
18
-
-
22544488092
-
Clinical relevance of postprandial lipaemia
-
Kolovou GD, Anagnostopoulou KK, Daskalopoulou SS, Mikhailidis DP, Cokkinos DV. Clinical relevance of postprandial lipaemia. Curr Med Chem 2005; 12: 1931-45.
-
(2005)
Curr Med Chem
, vol.12
, pp. 1931-1945
-
-
Kolovou, G.D.1
Anagnostopoulou, K.K.2
Daskalopoulou, S.S.3
Mikhailidis, D.P.4
Cokkinos, D.V.5
-
19
-
-
0026480744
-
Relation of triglyceride metabolism and coronary heart disease: Studies in the postprandial state
-
Patsch JR, Miesenbrock G, Hopferwieser T, et al. Relation of triglyceride metabolism and coronary heart disease: studies in the postprandial state. Arterioscler Thromb 1992; 12: 1336-45.
-
(1992)
Arterioscler Thromb
, vol.12
, pp. 1336-1345
-
-
Patsch, J.R.1
Miesenbrock, G.2
Hopferwieser, T.3
-
20
-
-
23244462620
-
Lipoprotein retention- and clues for atheroma regression
-
Williams KJ, Tabas I. Lipoprotein retention- and clues for atheroma regression. Arterioscler Thromb Vasc Biol 2005; 25: 1536-40.
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, pp. 1536-1540
-
-
Williams, K.J.1
Tabas, I.2
-
21
-
-
34447511196
-
Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women
-
Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. Jama 2007; 298: 299-308.
-
(2007)
Jama
, vol.298
, pp. 299-308
-
-
Nordestgaard, B.G.1
Benn, M.2
Schnohr, P.3
Tybjaerg-Hansen, A.4
-
22
-
-
33847055477
-
Improving prediction of ischemic cardiovascular disease in the general population usingapolipoprotein B: The Copenhagen City Heart Study
-
Benn M, Nordestgaard BG, Jensen GB, Tybjaerg-Hansen A. Improving prediction of ischemic cardiovascular disease in the general population usingapolipoprotein B: the Copenhagen City Heart Study. Arterioscler Thromb Vasc Biol 2007; 27: 661-70.
-
(2007)
Arterioscler Thromb Vasc Biol
, vol.27
, pp. 661-670
-
-
Benn, M.1
Nordestgaard, B.G.2
Jensen, G.B.3
Tybjaerg-Hansen, A.4
-
23
-
-
52149109922
-
Fasting compared with non-fastinglipids and apolipoproteins for predicting incident cardiovascular events
-
Mora S, Rifai N, Buring JE, Ridker PM. Fasting compared with non-fastinglipids and apolipoproteins for predicting incident cardiovascular events. Circulation 2008; 118: 993-1001.
-
(2008)
Circulation
, vol.118
, pp. 993-1001
-
-
Mora, S.1
Rifai, N.2
Buring, J.E.3
Ridker, P.M.4
-
24
-
-
0029741921
-
A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction
-
Stampfer MJ, Krauss RM, Ma J, et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 1996; 276: 882-824
-
(1996)
JAMA
, vol.276
, pp. 882-824
-
-
Stampfer, M.J.1
Krauss, R.M.2
Ma, J.3
-
25
-
-
0029741921
-
A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction
-
Stampfer MJ, Krauss RM, Ma J, et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 1996; 276: 882-8.
-
(1996)
JAMA
, vol.276
, pp. 882-888
-
-
Stampfer, M.J.1
Krauss, R.M.2
Ma, J.3
-
26
-
-
0027490520
-
Non-fasting serum triglyceride concentration and mortality from coronary heart disease and any cause in middle aged Norwegian women
-
Stensvold I, Tverdal A, Urdal P, Graff-Iversen S. Non-fasting serum triglyceride concentration and mortality from coronary heart disease and any cause in middle aged Norwegian women. BMJ 1993; 307: 1318-22.
-
(1993)
BMJ
, vol.307
, pp. 1318-1322
-
-
Stensvold, I.1
Tverdal, A.2
Urdal, P.3
Graff-Iversen, S.4
-
27
-
-
0037015288
-
Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: Effects of short and long-term simvastatin treatment
-
Ceriello A, Taboga C, Tonutti L, et al. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short and long-term simvastatin treatment. Circulation 2002; 106: 1211-8.
-
(2002)
Circulation
, vol.106
, pp. 1211-1218
-
-
Ceriello, A.1
Taboga, C.2
Tonutti, L.3
-
28
-
-
0037126729
-
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report
-
Third Report of the National Cholesterol Education Program (NCEP)
-
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-421.
-
(2002)
Circulation
, vol.106
, pp. 3143-3421
-
-
-
29
-
-
0021703067
-
Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects
-
Packard CJ, Munro A, Lorimer AR, Gotto AM, Shepherd J. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects. J Clin Invest 1984; 74: 2178-92.
-
(1984)
J Clin Invest
, vol.74
, pp. 2178-2192
-
-
Packard, C.J.1
Munro, A.2
Lorimer, A.R.3
Gotto, A.M.4
Shepherd, J.5
-
30
-
-
0005665079
-
Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans
-
Stalenhoef AF, Malloy MJ, Kane JP, Havel RJ. Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans. Proc Natl Acad Sci U S A 1984; 81: 1839-43.
-
(1984)
Proc Natl Acad Sci U S A
, vol.81
, pp. 1839-1843
-
-
Stalenhoef, A.F.1
Malloy, M.J.2
Kane, J.P.3
Havel, R.J.4
-
31
-
-
0023922609
-
Postprandial plasma lipoprotein changes in human subjects of different ages
-
Cohn JS, McNamara JR, Cohn SD, Ordovas JM, Schaefer EJ. Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res 1988; 29: 469-79.
-
(1988)
J Lipid Res
, vol.29
, pp. 469-479
-
-
Cohn, J.S.1
McNamara, J.R.2
Cohn, S.D.3
Ordovas, J.M.4
Schaefer, E.J.5
-
32
-
-
0027402281
-
Periprandial regulation of lipid metabolism in insulin-treated diabetes mellitus
-
Frayn KN, Coppack SW, Humphreys SM, Clark ML, Evans RD. Periprandial regulation of lipid metabolism in insulin-treated diabetes mellitus. Metabolism 1993; 42: 504-10.
-
(1993)
Metabolism
, vol.42
, pp. 504-510
-
-
Frayn, K.N.1
Coppack, S.W.2
Humphreys, S.M.3
Clark, M.L.4
Evans, R.D.5
-
33
-
-
84910110212
-
The insulin resistance syndrome: Impact on lipoprotein metabolism and atherothrombosis
-
Ginsberg HN, Huang LS. The insulin resistance syndrome: impact on lipoprotein metabolism and atherothrombosis J Cardiovasc Risk 2000; 7: 325-31.
-
(2000)
J Cardiovasc Risk
, vol.7
, pp. 325-331
-
-
Ginsberg, H.N.1
Huang, L.S.2
-
34
-
-
0028839110
-
Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans
-
Lewis GF, Uffelman KD, Szeto LW, et al. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest1995; 95: 158-66.
-
J Clin Invest1995
, vol.95
, pp. 158-166
-
-
Lewis, G.F.1
Uffelman, K.D.2
Szeto, L.W.3
-
35
-
-
0345396377
-
Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia
-
Patsch JR, Karlin JB, Scott LW, Smith LC, Gotto AM. Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia. Proc Natl Acad Sci U S A 1983; 80: 1449-53.
-
(1983)
Proc Natl Acad Sci U S A
, vol.80
, pp. 1449-1453
-
-
Patsch, J.R.1
Karlin, J.B.2
Scott, L.W.3
Smith, L.C.4
Gotto, A.M.5
-
36
-
-
0021676332
-
Postprandial lipemia. A key for the conversion of high density lipoprotein 2 into high density lipoprotein 3 by hepatic lipase
-
Patsch JR, Prasad S, Gotto AM, Bengtsson-Olivecrona G. Postprandial lipemia. A key for the conversion of high density lipoprotein 2 into high density lipoprotein 3 by hepatic lipase. J Clin Invest 1984; 74: 2017-23.
-
(1984)
J Clin Invest
, vol.74
, pp. 2017-2023
-
-
Patsch, J.R.1
Prasad, S.2
Gotto, A.M.3
Bengtsson-Olivecrona, G.4
-
37
-
-
0023160916
-
High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase
-
Patsch JR, Prasad S, Gotto AM Jr, Patsch W. High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest 1987; 80: 341-7.
-
(1987)
J Clin Invest
, vol.80
, pp. 341-347
-
-
Patsch, J.R.1
Prasad, S.2
Gotto, A.M.3
Patsch, W.4
-
38
-
-
0028172766
-
Low-density lipoproteins of the postprandial state induce cellular cholesteryl ester accumulation in macrophages
-
Lechleitner M, Hoppichler F, Föger B, Patsch JR. Low-density lipoproteins of the postprandial state induce cellular cholesteryl ester accumulation in macrophages. Arterioscler Thromb 1994; 14: 1799-807.
-
(1994)
Arterioscler Thromb
, vol.14
, pp. 1799-1807
-
-
Lechleitner, M.1
Hoppichler, F.2
Föger, B.3
Patsch, J.R.4
-
39
-
-
0030058975
-
Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway
-
Bjorkegren J, Packard CJ, Hamsten A, et al. Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway. J Lipid Res 1996; 37: 76-86.
-
(1996)
J Lipid Res
, vol.37
, pp. 76-86
-
-
Bjorkegren, J.1
Packard, C.J.2
Hamsten, A.3
-
41
-
-
0027424585
-
Relation of plasma levels and composition of apolipoprotein Bcontaining lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction
-
Tornvall P, Båvenholm P, Landou C, de Faire U, Hamsten A. Relation of plasma levels and composition of apolipoprotein Bcontaining lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction. Circulation 1993; 88(1): 2180-9.
-
(1993)
Circulation
, vol.88
, Issue.1
, pp. 2180-2189
-
-
Tornvall, P.1
Båvenholm, P.2
Landou, C.3
De Faire, U.4
Hamsten, A.5
-
42
-
-
0027485431
-
Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events
-
Phillips NR, Waters D, Havel RJ. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 1993; 88: 2762-70.
-
(1993)
Circulation
, vol.88
, pp. 2762-2770
-
-
Phillips, N.R.1
Waters, D.2
Havel, R.J.3
-
43
-
-
0028558979
-
Interactions amongst insulin, lipoproteins and haemostatic function relevant to coronary heart disease
-
Hamsten A, Karpe F, Båvenholm P, Silveira A. Interactions amongst insulin, lipoproteins and haemostatic function relevant to coronary heart disease. J Intern Med Suppl 1994; 736: 75-88.
-
(1994)
J Intern Med Suppl
, vol.736
, pp. 75-88
-
-
Hamsten, A.1
Karpe, F.2
Båvenholm, P.3
Silveira, A.4
-
44
-
-
0018649439
-
Atherogenesis: A postprandial phenomenon
-
Zilversmit DB. Atherogenesis: A postprandial phenomenon. Circulation 1979; 60: 473-85.
-
(1979)
Circulation
, vol.60
, pp. 473-485
-
-
Zilversmit, D.B.1
-
45
-
-
0025898720
-
Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease
-
Groot PHE, van Stiphout WAHJ, Krauss XH, et al. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscl Thromb 1991; 11: 653-62.
-
(1991)
Arterioscl Thromb
, vol.11
, pp. 653-662
-
-
Groot, P.1
Van Stiphout, W.2
Krauss, X.H.3
-
46
-
-
0034181352
-
Postprandial metabolism of apolipoprotein B 48-and B 100-containing particles in type 2 diabetes mellitus: Relations to angiographically verified severity of coronary artery disease
-
Syvänne M. Postprandial metabolism of apolipoprotein B 48-and B 100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease. Atherosclerosis 2000; 150: 167-177.
-
(2000)
Atherosclerosis
, vol.150
, pp. 167-177
-
-
Syvänne, M.1
-
47
-
-
0029597837
-
Association of postprandial triglyceride and retinyl palmitate responses with asymptomatic carotid artery atherosclerosis in middle-aged men and women
-
Sharrett AR, Chambless LE, Heiss G, Paton CC, Patsch W. Association of postprandial triglyceride and retinyl palmitate responses with asymptomatic carotid artery atherosclerosis in middle-aged men and women. Arterioscler Thromb Vasc Biol 1995; 15: 2122-9.
-
(1995)
Arterioscler Thromb Vasc Biol
, vol.15
, pp. 2122-2129
-
-
Sharrett, A.R.1
Chambless, L.E.2
Heiss, G.3
Paton, C.C.4
Patsch, W.5
-
48
-
-
0036242230
-
Increased postprandial lipemia in patients with normolipidemic peripheral arterial disease
-
Lupattelli G, Pasqualini L, Siepi D, et al. Increased postprandial lipemia in patients with normolipidemic peripheral arterial disease. Am Heart J 2002; 143: 733-8.
-
(2002)
Am Heart J
, vol.143
, pp. 733-738
-
-
Lupattelli, G.1
Pasqualini, L.2
Siepi, D.3
-
49
-
-
0033578450
-
Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle aged men
-
Boquist S, Ruotolo G, Tang R, Björkegren J, Bond MG, de Faire U, et al. Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle aged men. Circulation 1999; 100: 723-8.
-
(1999)
Circulation
, vol.100
, pp. 723-728
-
-
Boquist, S.1
Ruotolo, G.2
Tang, R.3
Björkegren, J.4
Bond, M.G.5
De Faire, U.6
-
50
-
-
0033851157
-
Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes
-
Teno S, Uto Y, Nagashima H, et al. Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes. Diabetes Care 2000; 23: 1401-6.
-
(2000)
Diabetes Care
, vol.23
, pp. 1401-1406
-
-
Teno, S.1
Uto, Y.2
Nagashima, H.3
-
51
-
-
0023277789
-
Chylomicrons and chylomicron remnants in coronary artery disease: A case-control study
-
Simons LA, Dwyer T, Simons J, et al. Chylomicrons and chylomicron remnants in coronary artery disease: a case-control study. Atherosclerosis 1987; 65, 181-9.
-
(1987)
Atherosclerosis
, vol.65
, pp. 181-189
-
-
Simons, L.A.1
Dwyer, T.2
Simons, J.3
-
52
-
-
0025651990
-
Postprandial lipaemia, fenofibrate and coronary artery disease
-
Simpson HS, Williamson CM, Olivecrona T, et al. Postprandial lipaemia, fenofibrate and coronary artery disease. Atherosclerosis 1990; 85: 193-202.
-
(1990)
Atherosclerosis
, vol.85
, pp. 193-202
-
-
Simpson, H.S.1
Williamson, C.M.2
Olivecrona, T.3
-
53
-
-
0028349617
-
Postprandial lipoproteins and progression of coronary atherosclerosis
-
Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 1994; 106: 83-97.
-
(1994)
Atherosclerosis
, vol.106
, pp. 83-97
-
-
Karpe, F.1
Steiner, G.2
Uffelman, K.3
Olivecrona, T.4
Hamsten, A.5
-
54
-
-
0028889579
-
Association of postprandial triglyceride and retinyl palmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged men and women
-
Ginsberg HN, Jones J, Blaner WS, et al. Association of postprandial triglyceride and retinyl palmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged men and women. Arterioscler Thromb Vasc Biol 1995; 15: 1829-38.
-
(1995)
Arterioscler Thromb Vasc Biol
, vol.15
, pp. 1829-1838
-
-
Ginsberg, H.N.1
Jones, J.2
Blaner, W.S.3
-
55
-
-
0034181352
-
Postprandial metabolism of apolipoprotein B 48-and B 100-containing particles in type 2 diabetes mellitus: Relations to angiographically verified severity of coronary artery disease
-
Mero N, Malmström R, Steiner G, Taskinen MR, Syvänne M. Postprandial metabolism of apolipoprotein B 48-and B 100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease. Atherosclerosis 2000; 150: 167-77.
-
(2000)
Atherosclerosis
, vol.150
, pp. 167-177
-
-
Mero, N.1
Malmström, R.2
Steiner, G.3
Taskinen, M.R.4
Syvänne, M.5
-
56
-
-
0030564992
-
Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: A case-control study
-
Meyer E, Westerveld HT, de Ruyter-Meijstek FC, et al. Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: a case-control study. Atherosclerosis 1996; 124: 221-35.
-
(1996)
Atherosclerosis
, vol.124
, pp. 221-235
-
-
Meyer, E.1
Westerveld, H.T.2
De Ruyter-Meijstek, F.C.3
-
57
-
-
0032844477
-
Hormone replacement therapy enhances postprandial lipid metabolism in postmenopausal women
-
Weintraub MS, Grosskopf I, Charach G, Eckstein N, Rubinstein A. Hormone replacement therapy enhances postprandial lipid metabolism in postmenopausal women. Metabolism 1999; 48: 1193-6.
-
(1999)
Metabolism
, vol.48
, pp. 1193-1196
-
-
Weintraub, M.S.1
Grosskopf, I.2
Charach, G.3
Eckstein, N.4
Rubinstein, A.5
-
59
-
-
0028172762
-
Triglyceride-rich lipoproteins isolated by selective-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque
-
Rapp JH, Lespine A, Hamilton RL, et al Triglyceride-rich lipoproteins isolated by selective-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. Arter Thromb 1994; 14: 1767-74.
-
(1994)
Arter Thromb
, vol.14
, pp. 1767-1774
-
-
Rapp, J.H.1
Lespine, A.2
Hamilton, R.L.3
-
60
-
-
0032693599
-
Atherosclerosis is an inflammatory disease
-
Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999; 138: S419-20.
-
(1999)
Am Heart J
, vol.138
, pp. S419-SS20
-
-
Ross, R.1
-
61
-
-
84865485915
-
Inflammation in atherosclerosis
-
Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 2012; 32: 2045-51.
-
(2012)
Arterioscler Thromb Vasc Biol
, vol.32
, pp. 2045-2051
-
-
Libby, P.1
-
62
-
-
0029910844
-
In vivo demonstration in humans that large triglyceride rich lipoproteins activate coagulation factor VII through the intrinsic coagulation pathway
-
Silveira A, Karpe F, Johnsson H, Bauer KA, Hamsten A. In vivo demonstration in humans that large triglyceride rich lipoproteins activate coagulation factor VII through the intrinsic coagulation pathway. Arterioscler Thromb Vasc Biol 1996; 16: 1333-9.
-
(1996)
Arterioscler Thromb Vasc Biol
, vol.16
, pp. 1333-1339
-
-
Silveira, A.1
Karpe, F.2
Johnsson, H.3
Bauer, K.A.4
Hamsten, A.5
-
63
-
-
0035992611
-
Postprandial lipemia is associated with platelet and monocyte activation and increased monocyte cytokine expression in normolipemic men
-
Hyson DA, Paglieroni TG, Wun T, Rutledge JC. Postprandial lipemia is associated with platelet and monocyte activation and increased monocyte cytokine expression in normolipemic men. Clin Appl Thromb Hemost 2002, 8: 147-55.
-
(2002)
Clin Appl Thromb Hemost
, vol.8
, pp. 147-155
-
-
Hyson, D.A.1
Paglieroni, T.G.2
Wun, T.3
Rutledge, J.C.4
-
64
-
-
79956319051
-
Progress and challenges in translating the biology of atherosclerosis
-
Libby P, Ridker PM, Hansson GK: Progress and challenges in translating the biology of atherosclerosis. Nature 2011; 473(7347): 317-25.
-
(2011)
Nature
, vol.473
, Issue.7347
, pp. 317-325
-
-
Libby, P.1
Ridker, P.M.2
Hansson, G.K.3
-
66
-
-
0029057589
-
Insulin resistance and lipoprotein metabolism
-
Taskinen MR: Insulin resistance and lipoprotein metabolism. Curr Opin Lipidol 1995; 6: 153-60.
-
(1995)
Curr Opin Lipidol
, vol.6
, pp. 153-160
-
-
Taskinen, M.R.1
-
67
-
-
3142729178
-
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
-
National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association
-
Grundy SM, Cleeman JL, Mercz CN. National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 2004; 110: 227-39.
-
(2004)
Circulation
, vol.110
, pp. 227-239
-
-
Grundy, S.M.1
Cleeman, J.L.2
Mercz, C.N.3
-
68
-
-
0024501678
-
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies
-
Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989; 79: 8-15.
-
(1989)
Circulation
, vol.79
, pp. 8-15
-
-
Gordon, D.J.1
Probstfield, J.L.2
Garrison, R.J.3
-
69
-
-
48549093490
-
National Lipid Association Taskforce on Non-HDL Cholesterol. The importance of non-HDL cholesterol reporting in lipid management
-
Blaha MJ, Blumenthal RS, Brinton EA, Jacobson TA. National Lipid Association Taskforce on Non-HDL Cholesterol. The importance of non-HDL cholesterol reporting in lipid management. J Clin Lipidol 2008; 2: 267-73.
-
(2008)
J Clin Lipidol
, vol.2
, pp. 267-273
-
-
Blaha, M.J.1
Blumenthal, R.S.2
Brinton, E.A.3
Jacobson, T.A.4
-
70
-
-
41249103856
-
Atherogenicity and Predictive Value of Non-High-Density Lipoprotein Cholesterol for Coronary Heart Disease
-
Miller M, et al. Atherogenicity and Predictive Value of Non-High-Density Lipoprotein Cholesterol for Coronary Heart Disease. Am J Cardiol 2008; 101: 1003-8.
-
(2008)
Am J Cardiol
, vol.101
, pp. 1003-1008
-
-
Miller, M.1
-
71
-
-
70450081001
-
Major lipids apolipoproteins, and risk of vascular disease
-
The Emerging Risk Factors Collaboration
-
The Emerging Risk Factors Collaboration. Major lipids apolipoproteins, and risk of vascular disease. JAMA 2009; 302: 1993-2000.
-
(2009)
JAMA
, vol.302
, pp. 1993-2000
-
-
-
72
-
-
21444438990
-
Vitamin E in the primary prevention of cardiovascular disease and cancer: The Women's Health Study: A randomized controlled trial
-
Lee IM, Cook NR, Gaziano JM, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005; 294: 56-65.
-
(2005)
JAMA
, vol.294
, pp. 56-65
-
-
Lee, I.M.1
Cook, N.R.2
Gaziano, J.M.3
-
73
-
-
0034912018
-
Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality
-
Cui Y, Blumenthal RS, Flaws JA, et al. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 2001; 161: 1413-9.
-
(2001)
Arch Intern Med
, vol.161
, pp. 1413-1419
-
-
Cui, Y.1
Blumenthal, R.S.2
Flaws, J.A.3
-
74
-
-
0034454766
-
Effect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older men
-
Purnell JQ, Kahn SE, Albers JJ, Nevin DN, Brunzell JD, Schwartz RS. Effect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older men. J Clin endocrinolMetab 2000; 85: 977-82.
-
(2000)
J Clin Endocrinolmetab
, vol.85
, pp. 977-982
-
-
Purnell, J.Q.1
Kahn, S.E.2
Albers, J.J.3
Nevin, D.N.4
Brunzell, J.D.5
Schwartz, R.S.6
-
75
-
-
0035897696
-
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adult (Adult TreatmentPanel III)
-
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP)
-
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adult (Adult TreatmentPanel III). JAMA 2001; 285: 2486-97.
-
(2001)
JAMA
, vol.285
, pp. 2486-2497
-
-
-
76
-
-
0038135048
-
Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: A metaanalysis of 60 controlled trials
-
Mensink RP, Zock PL, Kester AD, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a metaanalysis of 60 controlled trials. Am J Clin Nutr 2003; 77: 1146-55.
-
(2003)
Am J Clin Nutr
, vol.77
, pp. 1146-1155
-
-
Mensink, R.P.1
Zock, P.L.2
Kester, A.D.3
Katan, M.B.4
-
77
-
-
18644362774
-
Dietary fructose: Implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism
-
Havel PJ. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev 2005; 63: 133-57.
-
(2005)
Nutr Rev
, vol.63
, pp. 133-157
-
-
Havel, P.J.1
-
78
-
-
0037042231
-
The glycemic index: Physiological mechanism relating to obesity, diabetes, and cardiovascular disease
-
Ludwig DS. The glycemic index: physiological mechanism relating to obesity, diabetes, and cardiovascular disease. JAMA 2002; 287: 2414-23.
-
(2002)
JAMA
, vol.287
, pp. 2414-2423
-
-
Ludwig, D.S.1
-
79
-
-
0021821575
-
The reduction of plasma lipids, lipoproteins, and apoproteins in hypertriglyceridemic patients by dietary fish oils
-
Phillipson BE, Totkrock DW, Connor WE, Harris WS, Illingworth DR. The reduction of plasma lipids, lipoproteins, and apoproteins in hypertriglyceridemic patients by dietary fish oils. N Engl J Med 1985; 312: 1210.
-
(1985)
N Engl J Med
, vol.312
, pp. 1210
-
-
Phillipson, B.E.1
Totkrock, D.W.2
Connor, W.E.3
Harris, W.S.4
Illingworth, D.R.5
-
81
-
-
0345109256
-
Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione Trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico
-
GISSI-Prevenzione Investigators
-
GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione Trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Lancet 1999; 354: 447-55.
-
(1999)
Lancet
, vol.354
, pp. 447-455
-
-
-
82
-
-
0019181443
-
Effect of controlled alcohol feeding on triglycerides in patients with outpatient’alcohol hypertriglyceridemia’
-
Erkelens DW, Brunzell JD. Effect of controlled alcohol feeding on triglycerides in patients with outpatient’alcohol hypertriglyceridemia’. J Hum Nutr 1980; 34: 370-5.
-
(1980)
J Hum Nutr
, vol.34
, pp. 370-375
-
-
Erkelens, D.W.1
Brunzell, J.D.2
-
83
-
-
77956652380
-
Exercise prior to fat ingestion lowers fasting and postprandial VLDL and decreases adipose tissue IL-6 and GIP receptor mRNA in hypertriacylglycerolemic men
-
Dekker MJ, Graham TE, Ooi TC, Robinson LE. Exercise prior to fat ingestion lowers fasting and postprandial VLDL and decreases adipose tissue IL-6 and GIP receptor mRNA in hypertriacylglycerolemic men. J Nutr Biochem 2010; 21: 983-90.
-
(2010)
J Nutr Biochem
, vol.21
, pp. 983-990
-
-
Dekker, M.J.1
Graham, T.E.2
Ooi, T.C.3
Robinson, L.E.4
-
84
-
-
69249219155
-
Resistance exercise plus to aerobic activities is associated with better lipid’s profile among healthy individuals: The ATTICA study
-
Pitsavos C, Panagiotakos DB, Tambalis KD, et al. Resistance exercise plus to aerobic activities is associated with better lipid’s profile among healthy individuals: the ATTICA study. QJM 2009; 102: 609-16.
-
(2009)
QJM
, vol.102
, pp. 609-616
-
-
Pitsavos, C.1
Panagiotakos, D.B.2
Tambalis, K.D.3
-
85
-
-
70349342714
-
Effects of fibrates on lipid profiles and cardiovascular outcomes: A systematic review
-
Albourbih S, Filion KB, Joseph I, et al. Effects of fibrates on lipid profiles and cardiovascular outcomes: a systematic review. Am J Med 2009; 122: 1-8.
-
(2009)
Am J Med
, vol.122
, pp. 1-8
-
-
Albourbih, S.1
Filion, K.B.2
Joseph, I.3
-
86
-
-
3142550830
-
Fibrates for the treatment of the metabolic syndrome
-
Maki KC. Fibrates for the treatment of the metabolic syndrome. Curr Atheroscler Rep 2004; 6: 45-51.
-
(2004)
Curr Atheroscler Rep
, vol.6
, pp. 45-51
-
-
Maki, K.C.1
-
87
-
-
28044452217
-
Effects on long–term fenofibrate therapy on cardiovascular event in 9795 people with type 2 diabetes mellitus (The FIELD study): Randomised controlled trial
-
Keech A, Simes RJ, Barter P, et al. Effects on long–term fenofibrate therapy on cardiovascular event in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005; 366: 1849-61.
-
(2005)
Lancet
, vol.366
, pp. 1849-1861
-
-
Keech, A.1
Simes, R.J.2
Barter, P.3
-
88
-
-
0031938673
-
Overview of fenofibrate
-
Packard CJ. Overview of fenofibrate. Eur Heart J 1998; 19: A62-A65.
-
(1998)
Eur Heart J
, vol.19
, pp. A62-A65
-
-
Packard, C.J.1
-
89
-
-
0036040929
-
Effects of fibrates on serum metabolic parameters
-
Elisaf M. Effects of fibrates on serum metabolic parameters. Curr Med Res Opin 2002; 18: 269-76.
-
(2002)
Curr Med Res Opin
, vol.18
, pp. 269-276
-
-
Elisaf, M.1
-
90
-
-
33645730513
-
Cardioprotective properties of fibrates: Which fibrate, which patients, what mechanism?
-
Barter PJ, Rye KA. Cardioprotective properties of fibrates: which fibrate, which patients, what mechanism? Circulation 2006; 113: 1553-5.
-
(2006)
Circulation
, vol.113
, pp. 1553-1555
-
-
Barter, P.J.1
Rye, K.A.2
-
91
-
-
0023232216
-
Helsinki Heart Study: Primary – prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease
-
Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study: primary – prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987; 317: 1237-45.
-
(1987)
N Engl J Med
, vol.317
, pp. 1237-1245
-
-
Frick, M.H.1
Elo, O.2
Haapa, K.3
-
92
-
-
0026597808
-
Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentration on coronary heart disease risk in the Helsinki Heart Study: Implications for treatment
-
Manninen V, Tenkanen L, Koskinen P, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentration on coronary heart disease risk in the Helsinki Heart Study: implications for treatment. Circulation 1992; 85: 37-45.
-
(1992)
Circulation
, vol.85
, pp. 37-45
-
-
Manninen, V.1
Tenkanen, L.2
Koskinen, P.3
-
93
-
-
45149131667
-
Effects of intensive glucose lowering in type 2 diabetes
-
The Action to Control Cardiovascular Risk in Diabetes Study group
-
The Action to Control Cardiovascular Risk in Diabetes Study group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545-59.
-
(2008)
N Engl J Med
, vol.358
, pp. 2545-2559
-
-
-
94
-
-
77951704587
-
Effects of combination lipid therapy in type 2 diabetes mellitus
-
Ginsberg HN, Elam MB, Lovato LC, et al. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 2010; 362: 1563-74.
-
(2010)
N Engl J Med
, vol.362
, pp. 1563-1574
-
-
Ginsberg, H.N.1
Elam, M.B.2
Lovato, L.C.3
-
95
-
-
0034604225
-
Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: The Bezafibrate Infarction Prevention (BIP) study
-
The BIP Study Group
-
The BIP Study Group. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) study. Circulation 2000; 102: 21-7.
-
(2000)
Circulation
, vol.102
, pp. 21-27
-
-
-
97
-
-
22644437126
-
Nicotinic acid: The broad-spectrum lipid drug. A 50th anniversary review
-
Carlson IA. Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review. J Intern Med 2005; 258: 94-114.
-
(2005)
J Intern Med
, vol.258
, pp. 94-114
-
-
Carlson, I.A.1
-
98
-
-
73849123857
-
What’s the deal with niacin development: Is laropripanta dd-on therapy a winning strategy to beat a straight flush?
-
Bays HE, Ballantyne C. What’s the deal with niacin development: is laropripanta dd-on therapy a winning strategy to beat a straight flush? Curr Opin Lipidol 2009; 20: 467-76.
-
(2009)
Curr Opin Lipidol
, vol.20
, pp. 467-476
-
-
Bays, H.E.1
Ballantyne, C.2
-
99
-
-
34548190309
-
Lipid-lowering agents that cause druginduced hepatotoxicity
-
Bhardwaj SS, Chalasani N. Lipid-lowering agents that cause druginduced hepatotoxicity. Clin Liver Dis 2007; 11: 597-613.
-
(2007)
Clin Liver Dis
, vol.11
, pp. 597-613
-
-
Bhardwaj, S.S.1
Chalasani, N.2
-
100
-
-
18844401094
-
Nicotinic acid in the management of dyslipidemia associated with diabetes and metabolic syndrome: A position paper developed by European Consensus Panel
-
Shepherd J, Betteridge J, Van Gaal L. Nicotinic acid in the management of dyslipidemia associated with diabetes and metabolic syndrome: a position paper developed by European Consensus Panel. Curr Med Res Opin 2005; 21: 665-82.
-
(2005)
Curr Med Res Opin
, vol.21
, pp. 665-682
-
-
Shepherd, J.1
Betteridge, J.2
Van Gaal, L.3
-
101
-
-
0035969564
-
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease
-
Brown BG, Zhao XQ, Chait A, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001; 345: 1583-92.
-
(2001)
N Engl J Med
, vol.345
, pp. 1583-1592
-
-
Brown, B.G.1
Zhao, X.Q.2
Chait, A.3
-
102
-
-
84855171302
-
Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy
-
Boden WE, Probstfield JL, Anderson T, et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med 2011; 365: 2255-67.
-
(2011)
N Engl J Med
, vol.365
, pp. 2255-2267
-
-
Boden, W.E.1
Probstfield, J.L.2
Erson, T.3
-
103
-
-
0842324675
-
Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study)
-
Zhao XQ, Morse JS, Dowdy AA, et al. Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study). Am J Cardiol 2004; 93: 307-12.
-
(2004)
Am J Cardiol
, vol.93
, pp. 307-312
-
-
Zhao, X.Q.1
Morse, J.S.2
Dowdy, A.A.3
-
104
-
-
77953121328
-
Treatment Strategies in Atherosclerosis): Final results and the impact of medication adherence, dose, and treatment duration
-
The ARBITER 6-HALTS TRIAL (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol-6 HDL and LDL
-
Villines TC, Stanek EJ, Devine PJ, et al. The ARBITER 6-HALTS TRIAL (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol-6 HDL and LDL. Treatment Strategies in Atherosclerosis): final results and the impact of medication adherence, dose, and treatment duration. J Am Coll Cardiol 2010; 55: 2721-6.
-
(2010)
J am Coll Cardiol
, vol.55
, pp. 2721-2726
-
-
Villines, T.C.1
Stanek, E.J.2
Devine, P.J.3
-
105
-
-
70349742488
-
Effects of prescription omega-3-acid ethyl esters on lipoprotein particle concentrations, apolipoproteins AI and CIII, and lipoprotein-associated phospholipase A2 mass in statin-treated subjects with hypertriglyceridemia
-
Davidson MH, Maki KC, Bays H, et al. Effects of prescription omega-3-acid ethyl esters on lipoprotein particle concentrations, apolipoproteins AI and CIII, and lipoprotein-associated phospholipase A2 mass in statin-treated subjects with hypertriglyceridemia. J Clin Lipidol 2009; 3: 332-40.
-
(2009)
J Clin Lipidol
, vol.3
, pp. 332-340
-
-
Davidson, M.H.1
Maki, K.C.2
Bays, H.3
-
106
-
-
77953670912
-
Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid dose-dependently reduce fasting serum triglycerides
-
Musa-Veloso K, Binns MA, Kocenas AC, et al. Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid dose-dependently reduce fasting serum triglycerides. Nutr Rev 2010; 68: 155-67.
-
(2010)
Nutr Rev
, vol.68
, pp. 155-167
-
-
Musa-Veloso, K.1
Binns, M.A.2
Kocenas, A.C.3
-
107
-
-
77956635797
-
Low-dose eicosapentaenoic acid and/or docosahexaenoic acid and triglyceride lowering
-
Maki KC, Rains TM. Low-dose eicosapentaenoic acid and/or docosahexaenoic acid and triglyceride lowering. Nutr Rev 2010; 68: 567-8.
-
(2010)
Nutr Rev
, vol.68
, pp. 567-568
-
-
Maki, K.C.1
Rains, T.M.2
-
108
-
-
79251509572
-
Dose response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy person with moderate hypertriglyceridemia
-
Skulas-Ray AC, Kris-Etherton PM, Harris WS, et al. Dose response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy person with moderate hypertriglyceridemia. Am J Clin Nutr 2011; 93: 243-52.
-
(2011)
Am J Clin Nutr
, vol.93
, pp. 243-252
-
-
Skulas-Ray, A.C.1
Kris-Etherton, P.M.2
Harris, W.S.3
-
109
-
-
33947601804
-
Prescription omega-3 fatty acids from the treatment of hypertriglyceridemia
-
McKenney JM, Sica D. Prescription omega-3 fatty acids from the treatment of hypertriglyceridemia. Am J Health Syst Pharm 2007; 64: 595-605.
-
(2007)
Am J Health Syst Pharm
, vol.64
, pp. 595-605
-
-
McKenney, J.M.1
Sica, D.2
-
110
-
-
84889686400
-
Long-term safety and efficacy of TAK-085 in Japanese subjects with hypertriglyceridemia undergoing lifestyle modification: The omega-3 fatty acids randomized long-term (ORL) study
-
Tatsuno I, Saito Y, Kudou K, Ootake J. Long-term safety and efficacy of TAK-085 in Japanese subjects with hypertriglyceridemia undergoing lifestyle modification: The omega-3 fatty acids randomized long-term (ORL) study. J Clin Lipidol 2013; 7: 615-25.
-
(2013)
J Clin Lipidol
, vol.7
, pp. 615-625
-
-
Tatsuno, I.1
Saito, Y.2
Kudou, K.3
Ootake, J.4
-
111
-
-
49749128376
-
Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)
-
for the JELIS Investigators, Japan
-
Saito Y, Yokoyama M, Origasa H, et al. for the JELIS Investigators, Japan. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis 2008; 200: 135-40.
-
(2008)
Atherosclerosis
, vol.200
, pp. 135-140
-
-
Saito, Y.1
Yokoyama, M.2
Origasa, H.3
-
112
-
-
0042512336
-
European Guidelines on Cardiovascular Disease Prevention in Clinical Practice
-
Third Joint Task Force of European and Other Societies on Cardiovascular Prevention in Clinical PRACTICE
-
De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. Third Joint Task Force of European and Other Societies on Cardiovascular Prevention in Clinical PRACTICE. Eur Heart J 2003; 24: 1601-10.
-
(2003)
Eur Heart J
, vol.24
, pp. 1601-1610
-
-
De Backer, G.1
Ambrosioni, E.2
Borch-Johnsen, K.3
-
113
-
-
72649096155
-
Severe hypertriglyceridemia: An indication for apheresis?
-
Ewald N, Kloer HU. Severe hypertriglyceridemia: an indication for apheresis? Atheroscler Suppl 2009; 10: 49-52.
-
(2009)
Atheroscler Suppl
, vol.10
, pp. 49-52
-
-
Ewald, N.1
Kloer, H.U.2
-
114
-
-
84872834801
-
A three month-old infant with severe hyperchylomicronemia: Molecular diagnosis and extracorporeal treatment
-
Stefanutti C, Gozzer M, Pisciotta L, et al. A three month-old infant with severe hyperchylomicronemia: molecular diagnosis and extracorporeal treatment. Atheroscler Suppl 2013; 14: 73-6.
-
(2013)
Atheroscler Suppl
, vol.14
, pp. 73-76
-
-
Stefanutti, C.1
Gozzer, M.2
Pisciotta, L.3
-
115
-
-
8744220574
-
Plasmapheresis as an adjuvant therapy for hypertriglyceridemia-induced pancreatitis
-
Iskandar SB, Olive KE. Plasmapheresis as an adjuvant therapy for hypertriglyceridemia-induced pancreatitis. Am J Med Sci 2004; 328: 290-4.
-
(2004)
Am J Med Sci
, vol.328
, pp. 290-294
-
-
Iskandar, S.B.1
Olive, K.E.2
-
116
-
-
84860415876
-
Timing clinical events in the treatment of pancreatitis and hypertriglyceridemia with therapeutic plasmapheresis
-
Stefanutti C, Di Giacomo S, Labbadia G. Timing clinical events in the treatment of pancreatitis and hypertriglyceridemia with therapeutic plasmapheresis. Transfus Apher Sci 2011; 45: 3-7.
-
(2011)
Transfus Apher Sci
, vol.45
, pp. 3-7
-
-
Stefanutti, C.1
Di Giacomo, S.2
Labbadia, G.3
-
117
-
-
74049160452
-
Therapeutic plasma Exchange in patients with severe hypertrygliceridemia: A multicenter study
-
Stefanutti C, Di Giacomo S, Vivenzio A, et al. Therapeutic plasma Exchange in patients with severe hypertrygliceridemia: a multicenter study. Artif Organs 2009; 33: 1096-102.
-
(2009)
Artif Organs
, vol.33
, pp. 1096-1102
-
-
Stefanutti, C.1
Di Giacomo, S.2
Vivenzio, A.3
-
118
-
-
65449123928
-
Dyslipidemic pancreatitis clinical assessment and analysis of disease severity and outcomes
-
Anderson F, Thomson SR, Clarke DL, Buccimazza I. Dyslipidemic pancreatitis clinical assessment and analysis of disease severity and outcomes. Pancrteatology 2009; 9: 252-7.
-
(2009)
Pancrteatology
, vol.9
, pp. 252-257
-
-
Erson, F.1
Thomson, S.R.2
Clarke, D.L.3
Buccimazza, I.4
-
119
-
-
44349124449
-
Therapeutic plasma exchangefor acute hyperlipidemic pancreatitis: A case series
-
Al-Humoud H, Alhumoud E, Al-Hilali N. Therapeutic plasma exchangefor acute hyperlipidemic pancreatitis: a case series. Ther Apher Dial 2008; 12: 202-4.
-
(2008)
Ther Apher Dial
, vol.12
, pp. 202-204
-
-
Al-Humoud, H.1
Alhumoud, E.2
Al-Hilali, N.3
-
121
-
-
79960205374
-
ESC/EAS guidelines for the management of dyslipidemia. The Task Force for the management of dyslipidemia of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
-
European Society of Cardiology (ESC): European Atherosclerosis Society (EAS)
-
Catapano AL, Reiner Z, De Backer G, et al. European Society of Cardiology (ESC): European Atherosclerosis Society (EAS). ESC/EAS guidelines for the management of dyslipidemia. The Task Force for the management of dyslipidemia of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis 2011; 217: 3-46.
-
(2011)
Atherosclerosis
, vol.217
, pp. 3-46
-
-
Catapano, A.L.1
Reiner, Z.2
De Backer, G.3
-
122
-
-
85027956925
-
Triglyceridesand cardiovascular disease: A scientific statement from the American Heart Association
-
American Heart Association Clinical Lipidology, Thrombosis, and Prevention Committee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Nursing; Council on the Kidney in Cardiovascular Disease
-
Miller M, Stone NJ, Ballantyne C, et al. American Heart Association Clinical Lipidology, Thrombosis, and Prevention Committee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Nursing; Council on the Kidney in Cardiovascular Disease. Triglyceridesand cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2011; 123: 2292-333.
-
(2011)
Circulation
, vol.123
, pp. 2292-2333
-
-
Miller, M.1
Stone, N.J.2
Ballantyne, C.3
-
123
-
-
69249212383
-
Dyslipidemia and cardiovascular risk: The importance of early prevention
-
Miller M. Dyslipidemia and cardiovascular risk: the importance of early prevention. QJM 2009; 102(9): 657-67.
-
(2009)
QJM
, vol.102
, Issue.9
, pp. 657-667
-
-
Miller, M.1
-
124
-
-
84884995326
-
High-density lipoproteins: A consensus statement from the National Lipid Association
-
Toth PP, Barter PJ, Rosenson RS, et al. High-density lipoproteins: a consensus statement from the National Lipid Association. J Clin Lipidol 2013; 7: 484-525.
-
(2013)
J Clin Lipidol
, vol.7
, pp. 484-525
-
-
Toth, P.P.1
Barter, P.J.2
Rosenson, R.S.3
-
125
-
-
78049316310
-
Should we change our lipid management strategies to focus on non-high-density lipoprotein cholesterol?
-
Rana JS, Boekholdt SM. Should we change our lipid management strategies to focus on non-high-density lipoprotein cholesterol? Curr Opin Cardiol 2010; 25: 622-6.
-
(2010)
Curr Opin Cardiol
, vol.25
, pp. 622-626
-
-
Rana, J.S.1
Boekholdt, S.M.2
-
126
-
-
33846639147
-
Value of lowdensity lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: The EPIC-Norfolk Prospective Population Study
-
El Harchaoui K, van der Steeg WA, Stroes ES, et al. Value of lowdensity lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 2007; 49(5): 547-53.
-
(2007)
J am Coll Cardiol
, vol.49
, Issue.5
, pp. 547-553
-
-
El Harchaoui, K.1
Van Der Steeg, W.A.2
Stroes, E.S.3
-
127
-
-
79955595080
-
Diagnostic value of postprandial triglyceride testing in healthy subjects: A metaanalysis
-
Mihas C, Kolovou GD, Mikhailidis DP, et al. Diagnostic value of postprandial triglyceride testing in healthy subjects: a metaanalysis. Curr Vasc Pharmacol 2011; 9: 271-80.
-
(2011)
Curr Vasc Pharmacol
, vol.9
, pp. 271-280
-
-
Mihas, C.1
Kolovou, G.D.2
Mikhailidis, D.P.3
-
128
-
-
79955602730
-
Definition of postprandial lipaemia
-
Kolovou GD, Mikhailidis DP, Nordestgaard BG, Bilianou H, Panotopoulos G. Definition of postprandial lipaemia. Curr Vasc Pharmacol 2011; 9: 292-301.
-
(2011)
Curr Vasc Pharmacol
, vol.9
, pp. 292-301
-
-
Kolovou, G.D.1
Mikhailidis, D.P.2
Nordestgaard, B.G.3
Bilianou, H.4
Panotopoulos, G.5
-
129
-
-
79959919684
-
Pleiotropic effects of nicotinic acid: Beyond high density lipoprotein cholesterol elevation
-
Florentin M, Liberopoulos EN, Kei A, Mikhailidis DP, Elisaf MS. Pleiotropic effects of nicotinic acid: beyond high density lipoprotein cholesterol elevation. Curr Vasc Pharmacol 2011; 9: 385-400.
-
(2011)
Curr Vasc Pharmacol
, vol.9
, pp. 385-400
-
-
Florentin, M.1
Liberopoulos, E.N.2
Kei, A.3
Mikhailidis, D.P.4
Elisaf, M.S.5
-
130
-
-
84892366435
-
Remnant cholesterol as a cause of ischemic heart disease: Evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment
-
Nov 26. pii: S0163-7258(13)00226-X, [Epub ahead of print] PubMed PMID: 24287311
-
Varbo A, Benn M, Nordestgaard BG. Remnant cholesterol as a cause of ischemic heart disease: Evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment. Pharmacol Ther 2013 Nov 26. pii: S0163-7258(13)00226-X. doi: 10.1016/j.pharmthera2013.11.008. [Epub ahead of print] PubMed PMID: 24287311.
-
(2013)
Pharmacol Ther
-
-
Varbo, A.1
Benn, M.2
Nordestgaard, B.G.3
-
131
-
-
84876175810
-
Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction
-
Jørgensen AB, Frikke-Schmidt R, West AS, Grande P, Nordestgaard BG, Tybjærg-Hansen A. Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction. Eur Heart J 2013; 34: 1826-33.
-
(2013)
Eur Heart J
, vol.34
, pp. 1826-1833
-
-
Jørgensen, A.B.1
Frikke-Schmidt, R.2
West, A.S.3
Grande, P.4
Nordestgaard, B.G.5
Tybjærg-Hansen, A.6
-
132
-
-
79955398147
-
Nonfasting triglycerides, cholesterol, and ischemic stroke in the general population
-
Varbo A, Nordestgaard BG, Tybjaerg-Hansen A, Schnohr P, Jensen GB, Benn M. Nonfasting triglycerides, cholesterol, and ischemic stroke in the general population. Ann Neurol 2011; 69: 628-34.
-
(2011)
Ann Neurol
, vol.69
, pp. 628-634
-
-
Varbo, A.1
Nordestgaard, B.G.2
Tybjaerg-Hansen, A.3
Schnohr, P.4
Jensen, G.B.5
Benn, M.6
-
133
-
-
79955583131
-
Clinical relevance of non-fasting and postprandial hypertriglyceridemia and remnant cholesterol
-
Nordestgaard BG, Freiberg JJ. Clinical relevance of non-fasting and postprandial hypertriglyceridemia and remnant cholesterol. Curr Vasc Pharmacol 2011; 9: 281-6.
-
(2011)
Curr Vasc Pharmacol
, vol.9
, pp. 281-286
-
-
Nordestgaard, B.G.1
Freiberg, J.J.2
-
134
-
-
79959356255
-
Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: The Copenhagen City Heart Study with 31 years of follow-up
-
Langsted A, Freiberg JJ, Tybjaerg-Hansen A, Schnohr P, Jensen GB, Nordestgaard BG. Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-up. J Intern Med 2011; 270: 65-75.
-
(2011)
J Intern Med
, vol.270
, pp. 65-75
-
-
Langsted, A.1
Freiberg, J.J.2
Tybjaerg-Hansen, A.3
Schnohr, P.4
Jensen, G.B.5
Nordestgaard, B.G.6
-
135
-
-
79952214780
-
Nonfasting lipids, lipoproteins, and apolipoproteins in individuals with and without diabetes: 58 434 individuals from the Copenhagen General Population Study
-
Langsted A, Nordestgaard BG. Nonfasting lipids, lipoproteins, and apolipoproteins in individuals with and without diabetes: 58 434 individuals from the Copenhagen General Population Study. Clin Chem 2011; 57: 482-9.
-
(2011)
Clin Chem
, vol.57
, pp. 482-489
-
-
Langsted, A.1
Nordestgaard, B.G.2
-
136
-
-
84891601001
-
Effect of fructose on postprandial triglycerides: A systematic review and metaanalysis of controlled feeding trials
-
David Wang D, Sievenpiper JL, de Souza RJ, et al. Effect of fructose on postprandial triglycerides: A systematic review and metaanalysis of controlled feeding trials. Atherosclerosis 2014; 232(1): 125-33.
-
(2014)
Atherosclerosis
, vol.232
, Issue.1
, pp. 125-133
-
-
David Wang, D.1
Sievenpiper, J.L.2
De Souza, R.J.3
-
137
-
-
24044513689
-
Acute effects of acarbose on post-prandial glucose and triglycerides in type 2 diabetics following intake of different Malaysian foods
-
Nawawi HM, Yazid TN, Ismail F, Khalid BA. Acute effects of acarbose on post-prandial glucose and triglycerides in type 2 diabetics following intake of different Malaysian foods. Asia Pac J Clin Nutr 2000; 9: 41-5.
-
(2000)
Asia Pac J Clin Nutr
, vol.9
, pp. 41-45
-
-
Nawawi, H.M.1
Yazid, T.N.2
Ismail, F.3
Khalid, B.A.4
-
138
-
-
84893751761
-
Short-term effect of pitavastatin treatment on glucose and lipid metabolism and oxidative stress in fasting and postprandial state using a test meal in Japanese men
-
Kakuda H, Kobayashi J, Nakato M, Takekoshi N. Short-term effect of pitavastatin treatment on glucose and lipid metabolism and oxidative stress in fasting and postprandial state using a test meal in Japanese men. Cholesterol 2013; 2013: 314170.
-
(2013)
Cholesterol
, vol.2013
-
-
Kakuda, H.1
Kobayashi, J.2
Nakato, M.3
Takekoshi, N.4
-
139
-
-
84964194240
-
Early Improvement of Postprandial Lipemia After Bariatric Surgery in Obese Type 2 Diabetic Patients
-
Dec 30. [Epub ahead of print] PubMed PMID: 24374941
-
Griffo E, Nosso G, Lupoli R, et al. Early Improvement of Postprandial Lipemia After Bariatric Surgery in Obese Type 2 Diabetic Patients. Obes Surg 2013 Dec 30. [Epub ahead of print] PubMed PMID: 24374941.
-
(2013)
Obes Surg
-
-
Griffo, E.1
Nosso, G.2
Lupoli, R.3
-
140
-
-
84893514120
-
Mean postprandial triglyceride concentration is an independent risk factor for carotid atherosclerosis inpatients with type 2 diabetes
-
Dec 27. pii: S0009-8981(13)00517-2
-
Idei M, Hirayama S, Miyake N, et al. Mean postprandial triglyceride concentration is an independent risk factor for carotid atherosclerosis inpatients with type 2 diabetes. Clin Chim Acta 2013 Dec 27. pii: S0009-8981(13)00517-2. doi: 10.1016/j.cca 2013.12.022. [Epub ahead of print].
-
(2013)
Clin Chim Acta
-
-
Idei, M.1
Hirayama, S.2
Miyake, N.3
-
141
-
-
84926066475
-
Diets naturally rich in polyphenols improve fasting and postprandial dyslipidemia and reduce oxidative stress: A randomized controlled trial
-
Dec 24. [Epub ahead of print] PubMed PMID: 24368433
-
Annuzzi G, Bozzetto L, Costabile G, et al. Diets naturally rich in polyphenols improve fasting and postprandial dyslipidemia and reduce oxidative stress: a randomized controlled trial. Am J Clin Nutr 2013 Dec 24. [Epub ahead of print] PubMed PMID: 24368433.
-
(2013)
Am J Clin Nutr
-
-
Annuzzi, G.1
Bozzetto, L.2
Costabile, G.3
-
142
-
-
84890530969
-
Diurnal triglyceridemia in relation to alcohol intake in men
-
Torres do Rego A, Klop B, Birnie E, et al. Diurnal triglyceridemia in relation to alcohol intake in men. Nutrients 2013; 5(12): 5114-26.
-
(2013)
Nutrients
, vol.5
, Issue.12
, pp. 5114-5126
-
-
Torres Do Rego, A.1
Klop, B.2
Birnie, E.3
-
143
-
-
84899909678
-
SULF2 strongly prediposes to fasting and postprandial triglycerides in patients with obesity and type 2 diabetes mellitus
-
Dec 13, [Epub ahead of print]
-
Hassing HC, Surendran RP, Derudas B, et al. SULF2 strongly prediposes to fasting and postprandial triglycerides in patients with obesity and type 2 diabetes mellitus. Obesity (Silver Spring) 2013 Dec 13. doi: 10.1002/oby20682. [Epub ahead of print].
-
(2013)
Obesity (Silver Spring)
-
-
Hassing, H.C.1
Surendran, R.P.2
Derudas, B.3
-
144
-
-
84964194233
-
The glycemic/ metabolic responses to meal tolerance tests at breakfast, lunch and dinner, and effects of the mitiglinide/voglibose fixed-dose combination on postprandial profiles in Japanese patients with type 2 diabetes mellitus
-
Dec 13. [Epub ahead of print]
-
Ono Y, Nakamura A, Yong Cho K, Nomoto H. The glycemic/ metabolic responses to meal tolerance tests at breakfast, lunch and dinner, and effects of the mitiglinide/voglibose fixed-dose combination on postprandial profiles in Japanese patients with type 2 diabetes mellitus. Expert Opin Pharmacother 2013 Dec 13. [Epub ahead of print].
-
(2013)
Expert Opin Pharmacother
-
-
Ono, Y.1
Nakamura, A.2
Yong Cho, K.3
Nomoto, H.4
-
145
-
-
84894274848
-
Genetic Variation in SULF2 Is Associated with Postprandial Clearance of Triglyceride-Rich Remnant Particles and Triglyceride Levels in Healthy Subjects
-
Matikainen N, Burza MA, Romeo S, et al. Genetic Variation in SULF2 Is Associated with Postprandial Clearance of Triglyceride-Rich Remnant Particles and Triglyceride Levels in Healthy Subjects. PLoS One 2013 20; (11): e79473.
-
(2013)
Plos One
, vol.20
, Issue.11
-
-
Matikainen, N.1
Burza, M.A.2
Romeo, S.3
-
146
-
-
84887533343
-
The effects of dietary fatty acids on the postprandial triglyceride-rich lipoprotein/apoB48 receptor axis in human monocyte/ macrophage cells
-
Varela LM, Ortega-Gomez A, Lopez S, Abia R, Muriana FJ, Bermudez B. The effects of dietary fatty acids on the postprandial triglyceride-rich lipoprotein/apoB48 receptor axis in human monocyte/ macrophage cells. J Nutr Biochem 2013; 24(12): 2031-9.
-
(2013)
J Nutr Biochem
, vol.24
, Issue.12
, pp. 2031-2039
-
-
Varela, L.M.1
Ortega-Gomez, A.2
Lopez, S.3
Abia, R.4
Muriana, F.J.5
Bermudez, B.6
-
147
-
-
84872516435
-
Postprandial Peaking and Plateauing of Triglycerides and VLDL in Patients with Underlying Cardiovascular Diseases Despite Treatment
-
Samson CE, Galia AL, Llave KI, Zacarias MB, Mercado-Asis LB. Postprandial Peaking and Plateauing of Triglycerides and VLDL in Patients with Underlying Cardiovascular Diseases Despite Treatment. Int J Endocrinol Metab 2012; 10(4): 587-93.
-
(2012)
Int J Endocrinol Metab
, vol.10
, Issue.4
, pp. 587-593
-
-
Samson, C.E.1
Galia, A.L.2
Llave, K.I.3
Zacarias, M.B.4
Mercado-Asis, L.B.5
-
148
-
-
84882710903
-
The efficacy of Ezetimibe added to ongoing Fibrate-Statin therapy on postprandial lipid profile in the patients with type 2 Diabetes mellitus
-
Sharifi F, Hojeghani N, Mazloomzadeh S, Shajari Z. The efficacy of Ezetimibe added to ongoing Fibrate-Statin therapy on postprandial lipid profile in the patients with type 2 Diabetes mellitus. J Diabetes Metab Disord 2013; 12(1): 24.
-
(2013)
J Diabetes Metab Disord
, vol.12
, Issue.1
, pp. 24
-
-
Sharifi, F.1
Hojeghani, N.2
Mazloomzadeh, S.3
Shajari, Z.4
-
149
-
-
84885300888
-
Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat-rich meal in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, cross-over trial
-
Hermansen K, Baekdal TA, Düring M, et al. Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat-rich meal in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, cross-over trial. Diabetes Obes Metab 2013; 15(11): 1040-8.
-
(2013)
Diabetes Obes Metab
, vol.15
, Issue.11
, pp. 1040-1048
-
-
Hermansen, K.1
Baekdal, T.A.2
Düring, M.3
-
150
-
-
84920063295
-
Comparison between sitagliptin and nateglinide on postprandial lipid levels: The STANDARD study
-
Kojima Y, Kaga H, Hayashi S, et al. Comparison between sitagliptin and nateglinide on postprandial lipid levels: The STANDARD study. World J Diabetes 2013; 4: 8-13.
-
(2013)
World J Diabetes
, vol.4
, pp. 8-13
-
-
Kojima, Y.1
Kaga, H.2
Hayashi, S.3
-
151
-
-
84872020915
-
Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in nondiabetic subjects: A preliminary report
-
Noda Y, Miyoshi T, Oe H, et al. Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in nondiabetic subjects: a preliminary report. Cardiovasc Diabetol 2013; 12: 8.
-
(2013)
Cardiovasc Diabetol
, vol.12
, pp. 8
-
-
Noda, Y.1
Miyoshi, T.2
Oe, H.3
-
152
-
-
84878047441
-
The effect of vildagliptin therapy on atherogenic postprandial remnant particles and LDL particle size in subjects with type 2 diabetes
-
Matikainen N, Taskinen MR. The effect of vildagliptin therapy on atherogenic postprandial remnant particles and LDL particle size in subjects with type 2 diabetes. Diabet Med 2013; 30(6): 756-7.
-
(2013)
Diabet Med
, vol.30
, Issue.6
, pp. 756-757
-
-
Matikainen, N.1
Taskinen, M.R.2
-
153
-
-
84873823647
-
Effect of combination therapy with fenofibrate and simvastatin on postprandial lipemia in the ACCORD lipid trial
-
Reyes-Soffer G, Ngai CI, Lovato L, et al. Effect of combination therapy with fenofibrate and simvastatin on postprandial lipemia in the ACCORD lipid trial. Diabetes Care 2013; 36(2): 422-8.
-
(2013)
Diabetes Care
, vol.36
, Issue.2
, pp. 422-428
-
-
Reyes-Soffer, G.1
Ngai, C.I.2
Lovato, L.3
-
154
-
-
84873023759
-
GLP-1 and GLP-2 as yin and yang of intestinal lipoprotein production: Evidence for predominance of GLP-2-stimulated postprandial lipemia in normal and insulin-resistant states
-
Hein GJ, Baker C, Hsieh J, Farr S, Adeli K. GLP-1 and GLP-2 as yin and yang of intestinal lipoprotein production: evidence for predominance of GLP-2-stimulated postprandial lipemia in normal and insulin-resistant states. Diabetes 2013; 62(2): 373-81.
-
(2013)
Diabetes
, vol.62
, Issue.2
, pp. 373-381
-
-
Hein, G.J.1
Baker, C.2
Hsieh, J.3
Farr, S.4
Adeli, K.5
-
155
-
-
84868619241
-
Effect of ezetimibe on lipid and glucose metabolism after a fat and glucose load
-
Hiramitsu S, Miyagishima K, Ishii J, et al. Effect of ezetimibe on lipid and glucose metabolism after a fat and glucose load. J Cardiol 2012; 60: 395-400.
-
(2012)
J Cardiol
, vol.60
, pp. 395-400
-
-
Hiramitsu, S.1
Miyagishima, K.2
Ishii, J.3
-
156
-
-
84871738435
-
Double-blind randomized clinical trial of the effects of ezetimibe on postprandial hyperlipidaemia and hyperglycaemia
-
Kikuchi K, Nezu U, Inazumi K, et al. Double-blind randomized clinical trial of the effects of ezetimibe on postprandial hyperlipidaemia and hyperglycaemia. J Atheroscler Thromb 2012; 19: 1093-101.
-
(2012)
J Atheroscler Thromb
, vol.19
, pp. 1093-1101
-
-
Kikuchi, K.1
Nezu, U.2
Inazumi, K.3
-
157
-
-
84868563102
-
Effect of atorvastatin monotherapy and low-dose atorvastatin/ezetimibe combination on fasting and postprandial triglycerides in combined hyperlipidemia
-
Kostapanos MS, Elisaf MS, Mikhailidis DP. Effect of atorvastatin monotherapy and low-dose atorvastatin/ezetimibe combination on fasting and postprandial triglycerides in combined hyperlipidemia. J Cardiovasc Pharmacol Ther 2012; 17(4): 427.
-
(2012)
J Cardiovasc Pharmacol Ther
, vol.17
, Issue.4
, pp. 427
-
-
Kostapanos, M.S.1
Elisaf, M.S.2
Mikhailidis, D.P.3
-
158
-
-
84860504570
-
Ezetimibe ameliorates intestinal chylomicron overproduction and improves glucose tolerance in a diet-induced hamster model of insulin resistance
-
Naples M, Baker C, Lino M, Iqbal J, Hussain MM, Adeli K. Ezetimibe ameliorates intestinal chylomicron overproduction and improves glucose tolerance in a diet-induced hamster model of insulin resistance. Am J Physiol Gastrointest Liver Physiol 2012; 302(9): G1043-52.
-
(2012)
Am J Physiol Gastrointest Liver Physiol
, vol.302
, Issue.9
, pp. G1043-G1G52
-
-
Naples, M.1
Baker, C.2
Lino, M.3
Iqbal, J.4
Hussain, M.M.5
Adeli, K.6
-
159
-
-
79960698721
-
Ezetimibe improves postprandial hyperlipemia and its induced endothelial dysfunction
-
Yunoki K, Nakamura K, Miyoshi T, et al. Ezetimibe improves postprandial hyperlipemia and its induced endothelial dysfunction. Atherosclerosis 2011; 217: 486-91.
-
(2011)
Atherosclerosis
, vol.217
, pp. 486-491
-
-
Yunoki, K.1
Nakamura, K.2
Miyoshi, T.3
-
160
-
-
79960230767
-
Ezetimibe beneficially influences fasting and postprandial triglyceride-rich lipoproteins in type 2 diabetes
-
Bozzetto L, Annuzzi G, Corte GD, et al. Ezetimibe beneficially influences fasting and postprandial triglyceride-rich lipoproteins in type 2 diabetes. Atherosclerosis 2011; 217(1): 142-8.
-
(2011)
Atherosclerosis
, vol.217
, Issue.1
, pp. 142-148
-
-
Bozzetto, L.1
Annuzzi, G.2
Corte, G.D.3
|